Skip to main content

Table 1 Single-nucleotide polymorphism (SNP) sets reported significant association with coronary heart disease (CHD) or type 2 diabetes (T2D)

From: Disease patterns of coronary heart disease and type 2 diabetes harbored distinct and shared genetic architecture

SNP set

SKAT P values

Subjects (N)

SNPs (N)

Disease risk (%)

SNP composition (%)

OR > 1 (%)

CHD

T2D

CHD

T2D

CHD

T2D

G21

1.52E−03

8.76E−05

159

81

48

48

60

40

74

G22

2.79E−07

1.18E−01

70

34

26

29

50

50

0

G41

3.44E−04

5.19E−01

56

39

75

61

82

18

100

G55

2.79E−07

1.18E−01

53

24

6

58

100

0

0

G63

3.42E−04

7.08E−01

43

14

63

44

100

0

100

G74

1.33E−07

7.23E−01

37

25

16

51

100

0

0

G82

2.69E−05

7.12E−01

128

10

52

45

100

0

100

G84

2.12E−05

1.77E−01

42

14

26

62

71

29

29

G85

1.00E+00

3.84E−05

50

14

26

18

0

100

0

G92

3.09E−01

9.19E−06

42

10

31

43

70

30

30

G107

3.04E−01

1.49E−05

45

8

58

62

0

100

100

G125

5.97E−01

3.16E−05

73

6

42

62

0

100

100

G162

2.12E−05

1.77E−01

34

10

29

35

100

0

0

G164

2.79E−07

1.18E−01

23

17

9

52

100

0

0

G167

2.69E−01

2.12E−05

50

17

42

20

0

100

0

G168

2.79E−07

7.18E−01

24

15

17

29

100

0

0

G169

2.42E−05

1.28E−01

66

4

41

55

50

50

50

G1610

1.39E−01

7.36E−06

39

4

33

5

0

100

0

G1611

2.91E−05

6.06E−01

88

9

42

42

100

0

100

G1613

1.00E+00

7.54E−05

18

5

39

67

0

100

100

G1614

2.12E−05

1.18E−01

57

4

65

44

100

0

100

G1615

1.28E−01

3.17E−05

19

7

63

53

0

100

100

G1616

2.60E−05

5.60E−01

72

7

21

33

100

0

0